Rajmohan Murali - Concepedia

Author

Rajmohan Murali

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

For the GEM Study Group, MURALI R, Murali R, Murali R., R Murali, R. Murali, R.V. Murali, RM Vijay Murali, Rajmohan Murali, Rajmohan Murali (427214)

487

Publications

17.7K

Citations

H-Index

128

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Royal Prince Alfred Hospital The University of Sydney Melanoma Institute Australia Molecular Oncology (United States)

About

Rajmohan Murali is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	72	8.2K
2	Health Sciences	7	7	657
3	Engineering	2	2	146
4	Public Health	1	1	63
5	Biostatistics	1	1	23

Rajmohan Murali

139

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade Vivek Arora, Emily Schenkein, Rajmohan Murali, Cell Endocrine MechanismMedicineHormonal ReceptorGynecologyGlucocorticoid	2013	984
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma Farhad Azimi, Richard A. Scolyer, Pavlina Rumcheva, Journal of Clinical Oncology	2012	891
HER kinase inhibition in patients with HER2- and HER3-mutant cancers David M. Hyman, Sarina A. Piha‐Paul, Helen Won, Nature Tumor BiologyOncologyMedicineReceptor Tyrosine KinasePathology	2018	752
Germline mutations in BAP1 predispose to melanocytic tumors Thomas Wiesner, Anna C. Obenauf, Rajmohan Murali, Nature Genetics MelanomaPathologyGermline MutationsCancer GeneticsMedicine	2011	711
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas Thomas Wiesner, Jie He, Roman Yelensky, Nature Communications Tumor BiologyMedicineReceptor Tyrosine KinaseMelanomaPathology	2014	621
Copy number alteration burden predicts prostate cancer relapse Haley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, Proceedings of the National Academy of Sciences	2014	374
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia Sohela Shah, Kasmintan A. Schrader, Esmé Waanders, Nature Genetics Hematological MalignancyLymphoid NeoplasiaMixed-phenotype Acute LeukemiaGeneticsHematology	2013	320
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death Haley Hieronymus, Rajmohan Murali, Amy L. Tin, eLife Tumor BiologySurgical OncologyUrologyTumor HeterogeneityMedicine	2018	280
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway A. Hunter Shain, M Garrido, Thomas Botton, Nature Genetics Tumor BiologyTumor HeterogeneityExome SequencingGeneticsMedicine	2015	279
A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression Thomas Wiesner, Rajmohan Murali, Isabella Fried, The American Journal of Surgical Pathology Somatic VariantBraf MutationSkin CancerMedicineGenetics	2012	270

Page 1